ArticleEmerging infectious diseases2025
Emerging Trends in Streptococcal Toxic Shock Syndrome, Japan.
Article in Emerging infectious diseases, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 15 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
15 citing papers in PubMed.
- Tracing the recent evolution of Group AEmerging microbes & infections · 2026Review
- Predominance of M1European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology · 2026Article
- Complete genome sequences of 20Microbiology resource announcements · 2026Article
- Comparing virulence profile of dominantInfectious diseases & immunity · 2026Article
- Epidemiology and clinical characteristics of invasive group A streptococcal infection in the Republic of Korea, 2015-2024: a nationwide multicenter study.The Lancet regional health. Western Pacific · 2026Article
- A Case of Mediastinitis Due to Fulminant Group A Streptococcal Infection.Surgical case reports · 2026Article
- Mortality Among Patients With Invasive Group A Streptococcal Infections Caused by the M1UK Lineage: A Retrospective Cohort Study in England and Wales.Clinical infectious diseases : an official publication of the Infectious Diseases Society of America · 2025Article
- Streptococcal Toxic Shock Syndrome Following Intestinal Obstruction in a Patient With Crohn's Disease.Cureus · 2025Article
- Early Diagnosis of Streptococcal Toxic Shock Syndrome With Abdominal Computed Tomography: A Case Report.Cureus · 2025Article
- Engaging Broader Stakeholders to Accelerate Group AVaccines · 2025Review
- Resurgence of Group A Streptococcal Infections.Indian journal of pediatrics · 2025Review
- Trends in Group AMedicina (Kaunas, Lithuania) · 2025Observational
- Ongoing epidemic of scarlet fever in Shanghai and the emergence of M1The Lancet regional health. Western Pacific · 2025Article
- Global spread of Streptococcus pyogenes A genomics-supported narrative review.FEMS microbiology reviews · 2025Review
- Clinical and Microbiological Characteristics of Invasive Group A Streptococcus Infection: Four Case Series of Re-Emerging Pathogens.Acute medicine & surgeryArticle
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
1 author.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Japan experienced substantial increases in streptococcal toxic shock syndrome and group A Streptococcus pharyngitis after relaxing COVID-19 restrictions in May 2023. Increased detection of the M1
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.